APL-9796

N/A

Report date: 2025/04/25 11:15:54
First In Class

Base Information

Drug NameAPL-9796
Drug Alias NameAPL9796APL-9796AP-13
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Solute Carrier Family 39 Member 12
TargetsSolute Carrier Family 39 Member 12
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApollo Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApollo Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A